CyDex Pharmaceuticals, Inc.
CyDex Pharmaceuticals to Present at Cowen and Company's 30th Annual Health Care Conference
Published in Clinical Oncology Week, March 15th, 2010
"CyDex's Captisol technology improves the solubility and stability of a number of active pharmaceutical ingredients, and continues to be licensed by major pharmaceutical companies for a variety of therapies," said Odlaug. "In addition, we strengthened our patent portfolio and made significant advances in drug development during the past year, including completing an early proof-of-concept phase II clinical trial for a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- American Academy of Ophthalmology
HRT and cataract risk; smoking and uveitis - American College of Radiology / American Roentgen Ray Society
Ownership/leasing of PET scanners by nonradiologists on the rise - Dana-Farber Cancer Institute
Delaying post-surgical radiation increases risk of breast cancer recurrence in older women - Elsevier Health Sciences
Dietary factors influence ovarian cancer survival rates - Helmholtz Association of German Research Centres
Scientists discover cause of destructive inflammations - International Association for the Study of Lung Cancer
Lung cancer research explores the effects of patient attitudes on patient outcomes - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
